Catalyst Pharmaceutical
CPRX
CPRX
229 hedge funds and large institutions have $1.09B invested in Catalyst Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
22% more funds holding
Funds holding: 188 → 229 (+41)
9.36% more ownership
Funds ownership: 73.45% → 82.81% (+9.4%)
1% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 67
Holders
229
Holding in Top 10
5
Calls
$2.9M
Puts
$2.31M
Top Buyers
| 1 | +$107M | |
| 2 | +$62.8M | |
| 3 | +$27.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.4M |
| 5 |
Two Sigma Investments
New York
|
+$16.3M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$16.5M | |
| 3 | -$15.3M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$11M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$8.31M |